Eli Lilly Terminates Licensing Deal for Axiron

Buy Lab Tests Online

Jinzang

Member
From the financial press:

Acrux and US-based pharmaceutical giant Eli Lilly and Co agreed to end their licensing deal for Axiron, a testosterone replacement therapy for men. Axiron was the first testosterone replacement product that could be applied like a roll-on deodorant on the armpit of a patient. Acrux said generic treatments for testosterone deficiency were creating commercial uncertainty, and the testosterone market was declining.
The costs of a clinical trial required by the US Food and Drug Administration to determine whether an increased risk of heart attack or stroke exists among users of testosterone were also uncertain, the company said. Acrux is also appealing a US court decision that held that patents for the Axiron formulation were invalid.
 
Defy Medical TRT clinic doctor
Buy Lab Tests Online
Defy Medical TRT clinic

Sponsors

enclomiphene
nelson vergel coaching for men
Discounted Labs
TRT in UK Balance my hormones
Testosterone books nelson vergel
Register on ExcelMale.com
Trimix HCG Offer Excelmale
Thumos USA men's mentoring and coaching
Testosterone TRT HRT Doctor Near Me

Online statistics

Members online
1
Guests online
6
Total visitors
7

Latest posts

bodybuilder test discounted labs
Top